Voice of the Patient: Supporting FDA As Well As Educating FDA
This article was originally published in RPM Report
Executive Summary
The Food & Drug Administration’s patient-focused meetings are primarily listening sessions for the agency drug reviewers involved. But the FDA participants can go the next step and ask the patients for help with public debates. That happened at a recent session with fibromyalgia patients.